EU approves AstraZeneca’s drug for adjunct use in Type-1 diabetes

199

British drugmaker AstraZeneca Plc said on Monday the European Commission approved its diabetes drug Forxiga for use as an oral supplement to insulin in adults with a rare type of the disease.

http://feeds.reuters.com/~r/reuters/healthNews/~3/B58xo0ivSUQ/eu-approves-astrazenecas-drug-for-adjunct-use-in-type-1-diabetes-idUSKCN1R60QA